Collagen supplement for vulvar dryness in lichen sclerosus
Part of Skin, Women’s health & pregnancy clinical trials.
This study tests whether a supplement called Collagendep (which contains collagen and hyaluronic acid) can help reduce dryness in women with lichen sclerosus who are also having a fat grafting procedure. It aims to see if adding this supplement improves symptoms compared to the fat grafting alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have been diagnosed with lichen sclerosus in the genital area.
- Your doctor has recommended fat grafting (a procedure that uses your own fat) for your condition.
- You are willing to take the study product and attend all follow-up visits.
- You must not be pregnant or breastfeeding, have active infections, or have vulvar cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares three different treatments for vulvar lichen sclerosus (a skin condition that can cause itching and pain in the vulvar area): a steroid ointment, a calcineurin inhibitor ointment, and platelet-rich plasma (PRP) therapy. It aims to see which treatment works best to relieve symptoms.
This study tests whether a new topical treatment, StrataMGT, can reduce symptoms of vulvar lichen sclerosus. It is for women with moderate to severe symptoms who are already using a stable topical prescription.
This study compares a new non-invasive treatment using radiofrequency energy to a standard steroid cream for women with vulvar lichen sclerosus. The goal is to see which works better for symptom relief.
This study tests the drug methotrexate as a treatment for severe vulvar lichen sclerosus that has not responded to strong steroid creams. It aims to see if methotrexate can reduce symptoms and prevent further scarring.
This trial tests a cream called delgocitinib for adults with lichen sclerosus in the genital area. It aims to see if the cream can safely and effectively reduce symptoms over 52 weeks.
This study tests a new injectable medication called nemolizumab to see if it can reduce itching in women with lichen sclerosus affecting the genital area. If you have severe itching that hasn't been fully controlled by steroid creams, this might be an option to explore.
Hear when a new Vulvar Lichen Sclerosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.